Association between anxiety disorders and medication adherence in patients with cardiovascular disease: a systematic review and meta-analysis of observational studies - Scorecard - MDSpire
Advertisement
Association between anxiety disorders and medication adherence in patients with cardiovascular disease: a systematic review and meta-analysis of observational studies
Clinical Scorecard: Link Between Anxiety Disorders and Medication Compliance in Cardiovascular Disease Patients: A Systematic Review and Meta-Analysis of Observational Research
At a Glance
Category
Detail
Condition
Cardiovascular diseases with co-occurring anxiety disorders
Key Mechanisms
Anxiety disorders impair cognitive focus, energy, and motivation, leading to reduced medication adherence which increases morbidity and mortality in CV patients
Target Population
Adults aged 18 years and older diagnosed with cardiovascular disease and anxiety disorders
Care Setting
Outpatient and clinical settings managing cardiovascular disease patients
Key Highlights
Cardiovascular diseases are the leading cause of death globally, with significant mortality and economic burden.
Poor adherence to cardiovascular medications is linked to increased mortality, morbidity, and healthcare costs.
Anxiety disorders are prevalent in CV patients and negatively impact medication adherence, contributing to worse outcomes.
Guideline-Based Recommendations
Diagnosis
Use standardized questionnaires or clinical diagnosis to identify anxiety disorders in CV patients.
Management
Address anxiety disorders as part of comprehensive cardiovascular disease management to improve medication adherence.
Monitoring & Follow-up
Regularly assess medication adherence and psychological well-being in patients with cardiovascular disease.
Risks
Recognize that untreated anxiety can lead to poor medication adherence, increasing risk of cardiovascular events and mortality.
Patient & Prescribing Data
Adults with cardiovascular disease and coexisting anxiety disorders
Improving medication adherence by managing anxiety can reduce cardiovascular events and mortality; a 20% adherence improvement correlates with an 8% reduction in CV events and 12% reduction in mortality.
Clinical Best Practices
Incorporate routine screening for anxiety disorders in cardiovascular disease patients.
Implement multidisciplinary approaches including psychological support to enhance medication adherence.
Educate patients on the impact of anxiety on treatment adherence and cardiovascular outcomes.
Background music and multimedia exposure were associated with lower patient-reported anxiety in a quasi-experimental ophthalmology clinic study that used existing clinic audiovisual infrastructure at no additional cost.
